Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ASC1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA553458
Description
Immunogen sequence: ILQRDSNKSQ KLLKKLMSGV ENSGKVDIST KDLLPHQELR IKSGLEKAIK HKDKLLEFDR TSIRRTQVID DESDYFASDS NQWLSKLERE TLQKREEELR ELRHASRLSK KVTIDFAGRK ILEEENSLA Highest antigen sequence identity to the following orthologs: Mouse - 92%, Rat - 91%.
Transcription coactivator of nuclear receptors which functions in conjunction with CBP-p300 and SRC-1 and may play an important role in establishing distinct coactivator complexes under different cellular conditions. Plays a pivotal role in the transactivation of NF-kappa-B, SRF and AP1. Acts as a mediator of transrepression between nuclear receptor and either AP1 or NF-kappa-B. Plays a role in androgen receptor transactivation and in testicular function.
Specifications
ASC1 | |
Polyclonal | |
Unconjugated | |
Trip4 | |
4930558E03Rik; Activating signal cointegrator 1; Asc1; ASC-1; BB191711; HsT17391; SMABF1; thyroid hormone receptor interactor 4; thyroid receptor-interacting protein 4; transcription coactivator Asc1; TR-interacting protein 4; TRIP4; TRIP-4; ZC2HC5; zinc finger, C2HC5-type | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
315769, 56404, 9325 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
0.2 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q15650, Q9QXN3 | |
Trip4 | |
Recombinant protein corresponding to Human ASC1. Recombinant protein control fragment (Product #RP-89313). | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction